This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
Viewed By 12773 |
Epidemiology of metabolic dysfunction-associated steatotic liver disease |
Viewed By 7690 |
Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target |
Viewed By 7196 |
MAFLD: How is it different from NAFLD? |
Viewed By 5749 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 5693 |
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment |
Cited By 369 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 354 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 232 |
MAFLD: How is it different from NAFLD? |
Cited By 122 |
Non-alcoholic fatty liver disease: Definition and subtypes |
Cited By 116 |
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis |